Table of Contents
The number of people with chronic disease will increase further to nearly twelve million in 2050. Depression and osteoarthritis in particular are increasing dramatically. It is expected that the number of people with these diseases will double by 2050. This is evident from the new future Public Health vision (VTV) that the RIVM will soon publish.
RIVM November 19, 2024
The number of people with dementia will increase from 261,000 in 2022 to 506,000 in 2050. It’s not just old people: 6% of people with dementia are between 40 and 65 years old. Dementia mainly causes problems with memory, speech, recognition and performing daily tasks.
3 million people with osteoarthritis in 2050
The number of people with osteoarthritis (a form of rheumatism) is expected to rise from 1.6 million in 2022 to 3 million in 2050. Complaints associated with osteoarthritis include pain and (partial) paralysis. Other conditions that will become more common in 2050 include personal, work and sports accidents, neck and back problems and kidney failure. On the other hand, lung cancer, for example, is declining significantly.
More often several situations
The VTV (In the Public Health Future Outlook (VTV), the RIVM reports every four years on the development of public health in the Netherlands.) also shows that the number of people known to the doctor- have a family member with one or more illnesses increasing from 10 to 5 million in 2022 to nearly twelve million in 2050. The biggest increase is among people over 75. The number of people with three conditions or more rising from 3.3 to 4.3 million. So this number is increasing much faster than people with one or two chronic diseases.
About the VTV
The results mentioned above come from Outlook Health Public Future (VTV) 2024. The RIVM publishes the VTV every four years. In the VTV, RIVM discusses developments in public health and care up to 2050. The full report will be published on 27 November.
2024-11-20 10:14:00
#Doubling #number #people #dementia #osteoarthritis #PONT #ZorgSociaal
Questions for Guest #1:
1. As a healthcare professional, what are your thoughts on the dramatic increase in the number of people with depression and osteoarthritis? What measures can be taken to prevent or mitigate these conditions?
2. Do you foresee any challenges in providing adequate care for this growing patient population? How can healthcare policies and resources be adapted to address these challenges?
3. Would you say that the aging population is the main driver behind the rise in chronic diseases, or are there other factors at play? What can be done to promote overall public health and reduce the prevalence of chronic diseases among all age groups?
4. What role do lifestyle factors, such as diet and exercise, play in the prevention and management of chronic diseases? How can health campaigns effectively target individuals with multiple comorbidities?
5. As someone who works closely with patients and their families, what are the most important aspects of care that need to be addressed in order to support people living with chronic diseases? Do you see any gaps or areas for improvement in the current system?
Questions for Guest #2:
1. As a policy maker, how do you plan to address the anticipated increase in chronic diseases over the next few decades? Are there any specific initiatives or strategies being considered to improve overall public health and reduce the burden on the healthcare system?
2. What role should technology play in the management and prevention of chronic diseases? Are there any innovative solutions or technological advancements on the horizon that could help address these challenges?
3. How can healthcare providers work together more effectively to support patients with multiple chronic conditions? Are there any models of care that have been particularly successful in other countries or settings that could be considered for implementation in the Netherlands?
4. What are the most significant findings from the VTV report, and how should they inform public health policies and initiatives moving forward? Are there any under-researched areas that warrant further investigation?
5. What impact do you think the COVID-19 pandemic has had on the prevalence and management of chronic diseases in the Netherlands? Have there been any unforeseen consequences or lessons
